The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Camrelizumab combined with 2 cycles of chemotherapy as first-line treatment for advanced non-small cell lung cancer (NSCLC): A two-arm, single-center, phase 2 study.
 
Hongbing Liu
No Relationships to Disclose
 
Yueqin Ai
No Relationships to Disclose
 
Zhaofeng Wang
No Relationships to Disclose
 
Dongmei Yuan
No Relationships to Disclose
 
Ping Zhan
No Relationships to Disclose
 
Yanwen Yao
No Relationships to Disclose